Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
---|
08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
08/14/2002 | EP0960167B1 Bifluorophoric perylene colourants |
08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
08/13/2002 | US6432976 Analgesics; side effect reduction |
08/13/2002 | US6432948 Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases |
08/08/2002 | WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof |
08/08/2002 | US20020107392 Quinolinone derivatives |
08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
08/07/2002 | EP1228069A2 Bicyclic and tricyclic heteroaromatic compounds |
08/07/2002 | EP0760370B1 Novel carbapenem derivatives |
08/07/2002 | CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
08/06/2002 | US6429310 Photonic or electronic energy conducting |
08/01/2002 | WO2002059123A2 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds |
08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
08/01/2002 | WO2001003126A9 High density non-volatile memory device |
08/01/2002 | US20020103230 Heterocyclic compounds |
08/01/2002 | US20020103209 Serotonergic modulators; for treatment of disorders of the central nervous system including psychotic disorders, hypertension and vascular disorders, migraine |
08/01/2002 | US20020102597 Methods for selecting compounds for treating ischemia-related cellular damage |
08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
07/31/2002 | EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials |
07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
07/31/2002 | EP0735871B1 Pharmaceutical compositions containing ceftriaxone and penems |
07/31/2002 | EP0719267B1 Second messenger cell signaling inhibitors |
07/30/2002 | US6426350 Alpha-2 adrenoceptor antagonists; use treating nervous system disorders |
07/25/2002 | WO2002057271A2 Thienopyrimidine-based inhibitors of the src family |
07/25/2002 | WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
07/25/2002 | WO2002000653A3 Fused cyclic compounds as modulators of nuclear hormone receptor function |
07/25/2002 | US20020099055 Novel compounds |
07/25/2002 | CA2426775A1 Thienopyrimidine-based inhibitors of the src family |
07/23/2002 | US6423840 Forming n-acylamino compound |
07/18/2002 | WO2002055520A2 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds |
07/18/2002 | WO2002055083A1 TRIAZOLO[4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
07/18/2002 | WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
07/18/2002 | WO2002002557A3 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands |
07/18/2002 | US20020095061 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound |
07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
07/16/2002 | US6420553 Metallization a porphyrin to form metalloporprin |
07/16/2002 | US6420461 Compounds based on polyalkyl-1-oxadiazaspirodecane compounds |
07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
07/10/2002 | EP0690862B1 Quinolone derivatives and processes for preparing the same |
07/10/2002 | CN1358185A Optically active quinoline carboxylic acid derivatives having T-pyrrolidine substues causing optical activity and process for preparing thereof |
07/04/2002 | WO2002014317A3 Substituted pyrazoles |
07/04/2002 | US20020086871 Pharmaceutical composition for the treatment of CNS and other disorders |
07/04/2002 | US20020084446 Hyperpolarizable organic chromophores |
07/03/2002 | EP1219626A1 Compounds for fluorescence labeling |
07/03/2002 | EP1219622A2 Pharmaceutical compositions for CNS and other disorders |
07/03/2002 | CN1087018C Bis-pyrido [4,3-b] carbazole compounds, process for their prepn. and pharmaceutical compsns. contg. them |
06/27/2002 | WO2002000616A3 Novel cephalosporin compounds and process for preparing the same |
06/27/2002 | US20020082424 Alkylating an aryl halide with 1,3-dichloropropene and n-tetrabutylammonium iodide catalyst for forming vinyl chloride compound which is subjected to cyclization using tribuytyl tin hydride, catalyst and toluene as the solvent |
06/27/2002 | US20020081626 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample |
06/26/2002 | EP1216250A1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists |
06/26/2002 | EP1216247A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
06/26/2002 | EP1216244A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d 4? antagonists |
06/26/2002 | EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
06/26/2002 | CN1086706C Pyrido [3,2,1,i,j][3,1] benzoxazine derivatives |
06/25/2002 | US6410628 Photoactivatable nitrogen-containing bases based on alpha-amino ketones |
06/25/2002 | US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents |
06/20/2002 | WO2002048152A2 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
06/20/2002 | WO2002048145A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands |
06/20/2002 | WO2002048109A2 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators |
06/20/2002 | WO2002020013A3 A method for treating allergies using substituted pyrazoles |
06/20/2002 | US20020077503 Used to prepare one-pot systems with base-catalysable oligomers or monomers having storage stability; catalysts |
06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
06/19/2002 | EP1214322A2 Amino-triazolopyridine derivatives |
06/19/2002 | EP1214060A2 Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48 |
06/19/2002 | EP1196199A4 Water soluble multi-biotin-containing compounds |
06/19/2002 | EP1150984A4 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same |
06/18/2002 | US6406525 Dioxazine compounds containing sulphonic acid groups, dye for cotton or paper, printing inks; blue shades with excellent fastnesses |
06/13/2002 | WO2002020011A3 A method for treating allergies using substituted pyrazoles |
06/13/2002 | WO2002014315A3 Substituted pyrazoles |
06/13/2002 | WO2001097618A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
06/12/2002 | CN1353609A Amide substituted imidazoquinolines |
06/11/2002 | US6403809 Compounds for electronic devices |
06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
06/06/2002 | WO2002044176A1 3-substituted quinuclidines and their use as nicotinic agonists |
06/06/2002 | US20020068744 Interacting with tubulin and microtubules and promoting microtubule polymerization |
06/05/2002 | EP1210714A2 High density non-volatile memory device |
06/05/2002 | EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
06/05/2002 | EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders |
05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
05/30/2002 | WO2002042312A1 Novel carbapenem derivatives |
05/30/2002 | WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives |
05/30/2002 | WO2002005953A3 Asymmetric synthetic methods based on phase transfer catalysis |
05/30/2002 | WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes |
05/30/2002 | US20020065419 Cyclobutenedione compounds |
05/30/2002 | CA2429675A1 Novel carbapenem derivatives |
05/28/2002 | US6395724 Multibinding inhibitors of cyclooxygenase-2 |
05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
05/23/2002 | WO2002040455A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
05/23/2002 | WO2002039953A2 Texaphyrin coordination compounds and uses thereof |
05/23/2002 | US20020061908 S-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methy l-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid arginine salt microbiocides |
05/23/2002 | US20020059684 Including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings; absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings; dye conjugates; reactive dyes |
05/23/2002 | DE10122895A1 New lactam-substituted pyrazolo(3,4-b)pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation |
05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
05/23/2002 | CA2429411A1 Texaphyrin coordination compounds and uses thereof |
05/23/2002 | CA2428335A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |